Patent · US Active

4-benzyledene-piperidin derivatives

US8008326B2 · kind B2 · utility

17Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2005
Grant dateAug 30, 2011
Priority date—
Expiry dateNov 11, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new 4-benzylidene-piperidin derivatives of formula (I), useful as NMDA, in a particular NR2B subunit containing receptor antagonists and analgesica.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.